Autonomix Medical, Inc.
AMIX
$2.15
-$0.18-7.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -28.34% | 109.58% | 257.65% | 530.00% | 548.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.05% | 124.37% | 216.07% | 267.73% | 437.50% |
| Operating Income | 6.05% | -124.37% | -216.07% | -267.73% | -437.50% |
| Income Before Tax | 12.88% | 53.53% | -212.02% | -723.14% | -472.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.88% | 53.53% | -212.02% | -723.14% | -472.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.88% | 53.53% | -212.02% | -723.14% | -472.24% |
| EBIT | 6.05% | -124.37% | -216.07% | -267.73% | -437.50% |
| EBITDA | 7.29% | -- | -- | -- | -- |
| EPS Basic | 52.30% | 71.90% | -112.68% | -451.79% | -238.58% |
| Normalized Basic EPS | 52.30% | 71.90% | -112.68% | -451.78% | -238.57% |
| EPS Diluted | 52.30% | 71.90% | -112.68% | -451.79% | -238.58% |
| Normalized Diluted EPS | 52.30% | 71.90% | -112.68% | -451.78% | -238.57% |
| Average Basic Shares Outstanding | 82.63% | 65.38% | 46.71% | 49.16% | 69.00% |
| Average Diluted Shares Outstanding | 82.63% | 65.38% | 46.71% | 49.16% | 69.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
